Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor

Details for Australian Patent Application No. 2005286190 (hide)

Owner Pfizer Inc., Cancer Research Technology Ltd.

Inventors Kaufman, Rhonda; Curtin, Nicola Jane; Steinfeldt, Heidi Marie; Plummer, Elizabeth Ruth; Jones, Christopher; Stratford, Ian J.; Calvert, Alan Hilary; Boritzki, Theodore James; Reich, Steven David; Newell, David Richard; Thomas, Huw David; Hostomsky, Zdenek; Klamerus, Karen J.; Williams, Kaye Janine; Dewji, Mohamed Raza

Agent Allens Arthur Robinson

Pub. Number AU-A-2005286190

PCT Pub. Number WO2006/033006

Priority 60/683,006 19.05.05 US; 60/612,458 22.09.04 US

Filing date 9 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 31/282 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/704 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/033006 Priority application(s): WO2006/033006

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286191-Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phe nyl}-1,3,4,5-tetrahydro-6H-azepino[5,4, 3-cd]indol-6-one

2005286187-Method of preparing poly(ADP-ribose) polymerases inhibitors